Gregory Abel, MD, MPH

Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS1
- SINCE2008

Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
June 2008 - December 2010
Leukemia
Cordycepin Plus Pentostatin



